CausalSentinel

Protein Dossier — IFNLR1 (Interferon lambda receptor 1)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Parkinson’s disease 0.818 0.268 0.00227 Wald ratio 1 cis NA
Forearm bone mineral density -0.276 0.102 0.00712 Wald ratio 1 cis NA
Bulimia nervosa 0.152 0.0615 0.0136 Wald ratio 1 cis NA
Squamous cell lung cancer 0.362 0.17 0.0328 Wald ratio 1 cis NA
Lung cancer 0.24 0.115 0.0371 Wald ratio 1 cis NA
Autism 0.441 0.214 0.0389 Wald ratio 1 cis NA
Non-cancer illness code self-reported: osteoarthritis 0.0986 0.0487 0.0429 Wald ratio 1 cis NA
Lumbar spine bone mineral density -0.118 0.0605 0.0513 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hayfever or allergic rhinitis 0.113 0.0591 0.0555 Wald ratio 1 cis NA
Fasting insulin 0.0861 0.0451 0.0563 Wald ratio 1 cis NA
PGC cross-disorder traits 0.199 0.106 0.0593 Wald ratio 1 cis NA
Non-cancer illness code self-reported: psoriasis 0.227 0.122 0.0634 Wald ratio 1 cis NA
…and 70 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

31 association rows across 20 traits (25 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating IFNLR1 levels 1e-95 rs573848533 6 GCST90860236 no MR -> candidate analysis
IFNLR1 protein levels 3e-61 rs12751091 2 GCST90469518 no MR -> candidate analysis
Circulating IL22RA1 levels 1e-55 rs10903042 1 GCST90859872 no MR -> candidate analysis
FUCA1 protein levels 3e-52 rs10903035 2 GCST90469275 no MR -> candidate analysis
Interferon lambda receptor 1 levels 2e-36 rs139958347 2 GCST90248000 no MR -> candidate analysis
Psoriasis or type 2 diabetes (trans-disease meta-analysis) 2e-13 rs78312791 1 GCST011991 no MR -> candidate analysis
Psoriasis 9e-12 rs7552167 3 GCST005527 MR: beta=0.227, p=0.0634 (cis)
Psoriasis or type 2 diabetes (trans-disease meta-analysis)(o 3e-11 rs4649201 1 GCST011990 no MR -> candidate analysis
Psoriasis vulgaris 3e-11 rs7552167 2 GCST003268 no MR -> candidate analysis
Inflammatory skin disease 2e-9 rs10794648 1 GCST002740 no MR -> candidate analysis
Executive inhibition (word interference time) 8e-9 rs56226824 1 GCST90566353 no MR -> candidate analysis
Chronic inflammatory diseases (ankylosing spondylitis, Crohn 1e-8 rs7552167 1 GCST005537 no MR -> candidate analysis
…and 8 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 280 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
psoriasis 0.814 common-variant locus MR: beta=0.227, p=0.0634 (cis)
psoriasis vulgaris 0.622 common-variant locus no MR -> candidate analysis
type 2 diabetes mellitus 0.62 common-variant locus no MR -> candidate analysis
ankylosing spondylitis 0.501 common-variant locus no MR -> candidate analysis
ulcerative colitis 0.501 common-variant locus no MR -> candidate analysis
Crohn disease 0.501 common-variant locus no MR -> candidate analysis
sclerosing cholangitis 0.501 common-variant locus no MR -> candidate analysis
hyperpituitarism 0.417 common-variant locus no MR -> candidate analysis
acute tonsillitis 0.416 common-variant locus no MR -> candidate analysis
skin disorder 0.394 common-variant locus no MR -> candidate analysis

Of the 10 rows above, 9 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 1 known modulators (Interferon lambda receptor)
gnomAD constraint pLI=0.00015, LOEUF=0.732 — LoF-tolerant
GWAS Catalog 54 unique SNPs / 108 rows
ClinVar 115 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance